Search
Conduit Pharmaceuticals Inc
CDTAdd to Watchlist
2.930USD
+0.250+9.33%
Close 07-31 16:00（ET）Quotes delayed by 15 min
13.84MMarket Cap
LossP/E TTM
Shareholding Stats
Updated: Thu, May 7
Updated: Thu, May 7
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Prospect Capital Securities Ltd
30.25%
Prospect Finance Ltd
12.31%
Craig (Wigglesworth)
8.92%
Primary Development Fund (Cayman) SPC
8.58%
Nirland Limited
7.14%
Other
32.79%
Shareholders
Shareholders
Proportion
Prospect Capital Securities Ltd
30.25%
Prospect Finance Ltd
12.31%
Craig (Wigglesworth)
8.92%
Primary Development Fund (Cayman) SPC
8.58%
Nirland Limited
7.14%
Other
32.79%
Shareholder Types
Shareholders
Proportion
Corporation
62.33%
Individual Investor
15.53%
Investment Advisor/Hedge Fund
0.08%
Research Firm
0.01%
Other
22.04%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
71
4.64K
0.10%
+2.75K
2025Q4
81
20.07K
0.37%
--
2025Q3
83
20.07K
3.92%
+17.50K
2025Q2
96
2.58K
11.54%
-10.55K
2025Q1
96
13.01K
1.15%
+12.09K
2024Q4
115
728.00
11.67%
+390.00
2024Q3
109
338.00
13.69%
+91.00
2024Q2
94
246.00
16.08%
+107.00
2024Q1
73
139.00
15.73%
-829.00
2023Q4
64
117.00
14.00%
+98.00
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Russell 2000 Value ETF
0%
iShares Russell 2000 Growth ETF
0%
Global X Russell 2000 ETF
0%
ProShares UltraPro Russell2000
0%
ProShares Hedge Replication ETF
0%
Proshares Ultra Russell 2000
0%
iShares Micro-Cap ETF
0%
iShares Russell 2000 Value ETF
Proportion0%
iShares Russell 2000 Growth ETF
Proportion0%
Global X Russell 2000 ETF
Proportion0%
ProShares UltraPro Russell2000
Proportion0%
ProShares Hedge Replication ETF
Proportion0%
Proshares Ultra Russell 2000
Proportion0%
iShares Micro-Cap ETF
Proportion0%